Thoughts on Piper Sandler

Hello WSO community. I am currently exploring banking options and would like to focus on healthcare. My career center mentioned Piper Sandler. Any thoughts? (Would like to work in NY- if that matters)

23 Comments
 
Most Helpful

Spoke with someone there recently who said that conditions have improved since the wso post about their hours/culture. Obviously working hard still but think that they're definitely more cautious ever since that post

 

Does anyone have any insight on how Piper Sandler stacks up against other prominent MM players after it’s acquisition of Sandler O’Neil and The Valence Group.

 

TVG acquisition sets them up extremely well in the chemicals space (TVG routinely won bakeoffs against the BB's/EB's in chemicals transactions & senior mgmt is excellent). Sandler is a premier FIG name, of course.

Show me the incentive and I'll show you the outcome.
 

Keep in mind HC at Piper is split in 3 verticals - Medtech, HCIT, Biopharma. Biopharma you'll tend to do more cap markets deals / private placements / smaller deals than the other 2, but from an outsider's perspective I thought they had the best culture. Medtech is where Piper really earned its reputation in HC and is probably the strongest group out of all of "legacy" Piper (so excluding Simmons for Energy, Sandler for FIG). HCIT is super sweaty - active group though.

Above is a couple years out of date though and certainly Minneapolis focused, so anyone who's still there feel free to chime in. NY if I remember correctly wasn't split between the verticals and did more pharma / life sciences stuff as Tony said (also I think like anything that was animal health related).

 

??? What are you talking about? What is your source that Piper led Q1 M&A and what does that even mean? Size? Volume? Value? Industry?

 

Molestias eum beatae aut placeat. Molestias amet nam alias natus natus voluptas. In eligendi ab et consequatur reiciendis eius minus. Amet rerum unde nam minima.

Labore quia enim placeat corporis debitis dolorem nemo. Incidunt maiores blanditiis quidem cum dolore nam. Debitis debitis quisquam quia maxime ut.

Officia enim voluptatibus qui aliquam maiores quia. Et rerum porro iste mollitia exercitationem repellat quos. Cumque alias non quo. Veniam optio ut non deserunt tempora dolorum. Placeat reiciendis qui est et.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Guggenheim Partners 01 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 03 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
CompBanker's picture
CompBanker
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
DrApeman's picture
DrApeman
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”